Search research articles
Contact Us
Filters
Showing results (71-80 of 301) with videos related to
Page
of 31
Sort By:
Molecular Pharmacology
|
February 5, 2005
Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes
Debbie L Hay, George Christopoulos, Arthur Christopoulos, et al.
Endocrinology
|
April 4, 2017
Coexpressed Class B G Protein-Coupled Secretin and GLP-1 Receptors Self- and Cross-Associate: Impact on Pancreatic Islets
Kaleeckal G Harikumar, Shannen Lau, Patrick M Sexton, et al.
Biochemical Pharmacology
|
April 2, 2017
Characterization of signal bias at the GLP-1 receptor induced by backbone modification of GLP-1
Marlies V Hager, Lachlan Clydesdale, Samuel H Gellman, et al.
Advances in Experimental Medicine and Biology
|
March 22, 2012
RAMPs as drug targets
Patrick M Sexton, David R Poyner, John Simms, et al.
Biochemical Society Transactions
|
April 13, 2016
The complexity of signalling mediated by the glucagon-like peptide-1 receptor
Madeleine M Fletcher, Michelle L Halls, Arthur Christopoulos, et al.
Molecular Pharmacology
|
December 1, 2012
Allosteric modulation of a chemogenetically modified G protein-coupled receptor
Alaa Abdul-Ridha, J Robert Lane, Patrick M Sexton, et al.
Biochemistry
|
November 6, 2009
Molecular basis of association of receptor activity-modifying protein 3 with the family B G protein-coupled secretin receptor
Kaleeckal G Harikumar, John Simms, George Christopoulos, et al.
Molecular Pharmacology
|
June 6, 2015
Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor
Elham Khajehali, Daniel T Malone, Michelle Glass, et al.
Journal of the American Chemical Society
|
November 5, 2016
β-Arrestin-Biased Agonists of the GLP-1 Receptor from β-Amino Acid Residue Incorporation into GLP-1 Analogues
Marlies V Hager, Lisa M Johnson, Denise Wootten, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 30, 2015
Differential impact of amino acid substitutions on critical residues of the human glucagon-like peptide-1 receptor involved in peptide activity and small-molecule allostery
Cassandra Koole, Denise Wootten, John Simms, et al.
Page
of 31
Search research articles
Search
Showing results (71-80 of 301) with videos related to
Sort By:
Page
of 31
Molecular Pharmacology
|
February 5, 2005
Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes
Debbie L Hay, George Christopoulos, Arthur Christopoulos, et al.
Endocrinology
|
April 4, 2017
Coexpressed Class B G Protein-Coupled Secretin and GLP-1 Receptors Self- and Cross-Associate: Impact on Pancreatic Islets
Kaleeckal G Harikumar, Shannen Lau, Patrick M Sexton, et al.
Biochemical Pharmacology
|
April 2, 2017
Characterization of signal bias at the GLP-1 receptor induced by backbone modification of GLP-1
Marlies V Hager, Lachlan Clydesdale, Samuel H Gellman, et al.
Advances in Experimental Medicine and Biology
|
March 22, 2012
RAMPs as drug targets
Patrick M Sexton, David R Poyner, John Simms, et al.
Biochemical Society Transactions
|
April 13, 2016
The complexity of signalling mediated by the glucagon-like peptide-1 receptor
Madeleine M Fletcher, Michelle L Halls, Arthur Christopoulos, et al.
Molecular Pharmacology
|
December 1, 2012
Allosteric modulation of a chemogenetically modified G protein-coupled receptor
Alaa Abdul-Ridha, J Robert Lane, Patrick M Sexton, et al.
Biochemistry
|
November 6, 2009
Molecular basis of association of receptor activity-modifying protein 3 with the family B G protein-coupled secretin receptor
Kaleeckal G Harikumar, John Simms, George Christopoulos, et al.
Molecular Pharmacology
|
June 6, 2015
Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor
Elham Khajehali, Daniel T Malone, Michelle Glass, et al.
Journal of the American Chemical Society
|
November 5, 2016
β-Arrestin-Biased Agonists of the GLP-1 Receptor from β-Amino Acid Residue Incorporation into GLP-1 Analogues
Marlies V Hager, Lisa M Johnson, Denise Wootten, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 30, 2015
Differential impact of amino acid substitutions on critical residues of the human glucagon-like peptide-1 receptor involved in peptide activity and small-molecule allostery
Cassandra Koole, Denise Wootten, John Simms, et al.
Page
of 31